These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27027613)

  • 1. Function-Oriented Synthesis: How to Design Simplified Analogues of Antibacterial Nucleoside Natural Products?
    Ichikawa S
    Chem Rec; 2016 Jun; 16(3):1106-15. PubMed ID: 27027613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria.
    Ii K; Ichikawa S; Al-Dabbagh B; Bouhss A; Matsuda A
    J Med Chem; 2010 May; 53(9):3793-813. PubMed ID: 20405928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of isoxazolidine-containing uridine derivatives as caprazamycin analogues.
    Yamaguchi M; Matsuda A; Ichikawa S
    Org Biomol Chem; 2015 Jan; 13(4):1187-97. PubMed ID: 25428330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Nucleoside Natural Products Inhibiting Phospho-MurNAc-Pentapeptide Translocase; Chemistry and Structure-Activity Relationship.
    Ichikawa S; Yamaguchi M; Matsuda A
    Curr Med Chem; 2015; 22(34):3951-79. PubMed ID: 26282943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles.
    Pae AN; Kim HY; Joo HJ; Kim BH; Cho YS; Choi KI; Choi JH; Koh HY
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2679-84. PubMed ID: 10509915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of nucleoside antibacterial natural product antibiotics.
    Bugg TDH; Kerr RV
    J Antibiot (Tokyo); 2019 Dec; 72(12):865-876. PubMed ID: 31471595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.
    Valdes-Pena MA; Massaro NP; Lin YC; Pierce JG
    Acc Chem Res; 2021 Apr; 54(8):1866-1877. PubMed ID: 33733746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muraymycin Nucleoside Antibiotics: Structure-Activity Relationship for Variations in the Nucleoside Unit.
    Heib A; Niro G; Weck SC; Koppermann S; Ducho C
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterocyclic nucleoside analogues: design and synthesis of antiviral, modified nucleosides containing isoxazole heterocycles.
    Lee YS; Kim BH
    Bioorg Med Chem Lett; 2002 May; 12(10):1395-7. PubMed ID: 11992785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analogues of Muraymycin Nucleoside Antibiotics with Epimeric Uridine-Derived Core Structures.
    Spork AP; Koppermann S; Schier Née Wohnig S; Linder R; Ducho C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxazolomycins: natural product lead structures for novel antibacterials by click fragment conjugation.
    Bagwell CL; Moloney MG; Yaqoob M
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2090-4. PubMed ID: 20223659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine synthetic nucleoside chemistry based on nucleoside natural products synthesis.
    Ichikawa S
    Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1059-72. PubMed ID: 18670104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro antibacterial activity of oxazolidine LBM-415 analogs as peptide deformylase inhibitors.
    Yu L; Zhou W; Wang Z
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1541-4. PubMed ID: 21288715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores.
    Patel B; Kerr RV; Malde AK; Zunk M; Bugg TDH; Grant G; Rudrawar S
    ChemMedChem; 2020 Aug; 15(15):1429-1438. PubMed ID: 32476294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity.
    Takahashi Y; Igarashi M; Miyake T; Soutome H; Ishikawa K; Komatsuki Y; Koyama Y; Nakagawa N; Hattori S; Inoue K; Doi N; Akamatsu Y
    J Antibiot (Tokyo); 2013 Mar; 66(3):171-8. PubMed ID: 23532021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterials. synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivatives.
    Park CH; Brittelli DR; Wang CL; Marsh FD; Gregory WA; Wuonola MA; McRipley RJ; Eberly VS; Slee AM; Forbes M
    J Med Chem; 1992 Mar; 35(6):1156-65. PubMed ID: 1552508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents.
    Hirano S; Ichikawa S; Matsuda A
    Bioorg Med Chem; 2008 Jan; 16(1):428-36. PubMed ID: 17904373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.
    Patel B; Ryan P; Makwana V; Zunk M; Rudrawar S; Grant G
    Eur J Med Chem; 2019 Jun; 171():462-474. PubMed ID: 30933853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of 5'-C-piperidinyl-5'-O-aminoribosyluridines as potential antibacterial agents.
    Nakaya T; Matsuda A; Ichikawa S
    Org Biomol Chem; 2015 Jul; 13(28):7720-35. PubMed ID: 26090936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry and structure-activity relationship of antibacterial nucleoside natural products.
    Ichikawa S; Matsuda A
    Nucleic Acids Symp Ser (Oxf); 2008; (52):77-8. PubMed ID: 18776261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.